Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
12/07/2000 | CA2374222A1 Cytoskeleton-associated proteins |
12/07/2000 | CA2374133A1 Structural models for cytoplasmic domains of transmembrane receptors |
12/07/2000 | CA2372249A1 Chemokine receptor ccr3 antagonists |
12/07/2000 | CA2372234A1 Oxazaheterocycles as protease inhibitors |
12/07/2000 | CA2370598A1 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors |
12/06/2000 | EP1057827A1 Spiropiperidine derivatives |
12/06/2000 | EP1056842A2 Genetic vaccine vector engineering |
12/06/2000 | EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
12/06/2000 | EP1056768A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
12/06/2000 | EP1056760A1 36 human secreted proteins |
12/06/2000 | EP1056759A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
12/06/2000 | EP1056754A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone |
12/06/2000 | EP1056731A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone |
12/06/2000 | EP1056730A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone |
12/06/2000 | EP1056728A1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines |
12/06/2000 | EP1056455A1 Epimorphian compound and its use |
12/06/2000 | EP1056452A1 Indole-3-propionic acids, salts and esters thereof used as medicaments |
12/06/2000 | EP1056451A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors |
12/06/2000 | CN1275564A Quinoline ketone derivant and antianaphylaction using same as active substance |
12/06/2000 | CN1059125C Traditional Chinese medicine for treating chronic bronchitis |
12/06/2000 | CN1059107C Medicinal composition for treating chronic obstructive disease of lung and its preparing process |
12/06/2000 | CN1059090C Syrup for treating cough and asthma and productive method thereof |
12/05/2000 | US6156887 Compositions and methods for the treatment and diagnosis of immune disorders |
12/05/2000 | US6156788 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
12/05/2000 | US6156781 Antiinflammatory agents for skin |
12/05/2000 | US6156756 Anticoagulants |
12/05/2000 | US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists |
12/05/2000 | US6156750 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
12/05/2000 | US6156734 Cardiovascular disorders |
12/05/2000 | US6156523 Serine/threonine protein kinases |
11/30/2000 | WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
11/30/2000 | WO2000071718A1 Gene therapy of pulmonary disease |
11/30/2000 | WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes |
11/30/2000 | WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them |
11/30/2000 | WO2000071548A1 Substituted imidazothiazoles as antidepressant agents |
11/30/2000 | WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
11/30/2000 | WO2000071537A1 New pharmaceutically active compounds |
11/30/2000 | WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE |
11/30/2000 | WO2000071529A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
11/30/2000 | WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
11/30/2000 | WO2000071424A1 Method and apparatus for distributing powder |
11/30/2000 | WO2000071419A1 Method and apparatus for loading a container with a product |
11/30/2000 | WO2000071150A1 Tumor necrosis factor receptor 5 |
11/30/2000 | WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
11/30/2000 | WO2000071118A1 Phospholipase a2-specific inhibiting compounds |
11/30/2000 | WO2000071114A1 Salts of cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate] |
11/30/2000 | WO2000071108A2 Methods for treatment of asthma using s-oxybutynin |
11/30/2000 | WO2000071107A2 New pharmaceutical combinations for nos inhibitors |
11/30/2000 | WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor |
11/30/2000 | WO2000043413A3 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
11/30/2000 | WO2000042993A3 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery |
11/30/2000 | WO2000042072A3 Polypeptide variants with altered effector function |
11/30/2000 | WO2000041694A3 Compositions having improved stability |
11/30/2000 | WO2000041693A3 Compositions having improved delivery of actives |
11/30/2000 | WO2000041692A3 Compositions having improved stability |
11/30/2000 | WO2000040241A3 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
11/30/2000 | WO2000034338A3 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
11/30/2000 | WO2000028019A3 Antisense oligomer |
11/30/2000 | WO2000027363A9 Aerosols comprising nanoparticle drugs |
11/30/2000 | WO2000024391A3 Conductance of improperly folded proteins through the secretory pathway |
11/30/2000 | DE19924818A1 Substituierte Phenylcyclohexancarbonsäureamide Substituted Phenylcyclohexancarbonsäureamide |
11/30/2000 | CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
11/30/2000 | CA2375543A1 Salts of cis-¬4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate| |
11/30/2000 | CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them |
11/30/2000 | CA2374915A1 Substituted imidazothiazoles as antidepressant agents |
11/30/2000 | CA2374674A1 Tumor necrosis factor receptor 5 |
11/30/2000 | CA2374668A1 New pharmaceutical combinations for nos inhibitors |
11/30/2000 | CA2374432A1 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
11/30/2000 | CA2373783A1 Method and apparatus for loading a container with a product |
11/30/2000 | CA2373588A1 Gene therapy of pulmonary disease |
11/30/2000 | CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds |
11/30/2000 | CA2372743A1 New pharmaceutically active compounds |
11/30/2000 | CA2372580A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
11/30/2000 | CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase |
11/30/2000 | CA2371923A1 Methods for treatment of asthma using s-oxybutynin |
11/29/2000 | EP1055665A1 3-(3-Hydroxyphenyl)-3-amino-propionamide derivatives |
11/29/2000 | EP1054995A1 GABAB-R2a, A 7TM RECEPTOR |
11/29/2000 | EP1054904A1 Mucilage, a g-protein-coupled receptor |
11/29/2000 | EP1054900A1 Therapeutic uses of keratinocyte growth factor-2 |
11/29/2000 | EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
11/29/2000 | EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use |
11/29/2000 | EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors |
11/29/2000 | EP1054685A1 Liquid crystal forms of cyclosporin |
11/29/2000 | EP0655055B1 Tachykinin antagonists |
11/29/2000 | CN1275128A Pyrazolo (3,4-D) pyrimidines with anticonvulsive and antialiergic/antiasthmatic action |
11/29/2000 | CN1275076A Method of administering liposomal encapsulated taxane |
11/29/2000 | CN1275052A Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
11/29/2000 | CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives |
11/29/2000 | CN1274601A Immunity-strengthening and infection-preventing medicine |
11/29/2000 | CN1058968C Novel pyrido [3,2-e] pyrazinones with anti-asthmatic action and process for their manufacture |
11/29/2000 | CN1058894C Compound cold-preventing nose drops and their preparation |
11/29/2000 | CN1058891C Medicine for treating child asthma type bronchitis |
11/29/2000 | CN1058883C Chinese medicine preparation for treatment of bronchial asthma |
11/29/2000 | CN1058874C Medical composition against snore and preparation and application thereof |
11/28/2000 | US6153630 Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same |
11/28/2000 | US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists |
11/28/2000 | US6153189 Human TRK receptors and neurotrophic factor inhibitors |
11/28/2000 | US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor |
11/28/2000 | CA2267136C Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
11/28/2000 | CA2137348C Synthetic peptide lung surfactants having covalently bonded antioxidants |